Mikhail Blagsoklonny earned both his M.D. and PhD in St. Petersburg from the First Pavlov State Medical University. He also took a position as senior scientist in New York at the Ordway Institute. He has also held a position at the Park Cancer Research as professor of Oncology. Perhaps he is most famous for his work in the medical field for research in the fields of cancer and aging. Rapamycin is the drug that hopes will help extend the life of cancer patients.
Extending the Life of Patients
While rapamycin appears to possess qualities that extend life in lab tests for mice, it is clearly shows promise for impacting the aging process. It shows properties of being able to suppress tumors, which can be the main cause of death. Aging results from a break down in the body’s ability to repair itself. When this happens in older people, the signs of wear and tear become more prominent. Then, older individuals are at an increased risk for diabetes, Alzheimer’s disease, cancer, and cardiovascular diseases. If scientists can influence the aging process, it will represent a leap forward for medicine and science.
Oncotarget is an open access medical journal that receives weekly, updated, peer reviews. Established in 2010. It serves as a critical source of information and thought for medical industry professionals. For those who want to contribute, they simply need to provide a citation for the original article, indicate the work’s originator, its volume, and the date the original author introduced the article. It is adherence to this rule that allows people to make contributions to Oncotarget, and to help ensure their work is free and available to others.Dr. Blagosklonny has published over 300 articles medical research. His works also include books and book reviews. His literary contributions include serving as Associated in Editor for Cancer Biology &Therapy, and the American Journal of Pathology to name several. Blagosklonny is an individual that dedicates his life to a cause. He is able in part because of an excellent education that has contributed a great deal to his experience, vision, and reach. Blagosklonny is highly respected for his unyielding research efforts with respect to aging and cancer. It is his relentless search for knowledge, beginning in Russia, that has led him to where he is today. He came to America in 2002 with impressive academic papers. The New York Medical College hired him as a professor of medicine. He was also appointed to the position of senior scientist at the Ordway Research Institute during the same period.